Literature DB >> 19805703

Positron emission tomography measures of endogenous opioid neurotransmission and impulsiveness traits in humans.

Tiffany M Love1, Christian S Stohler, Jon-Kar Zubieta.   

Abstract

CONTEXT: The endogenous opioid system and opioid mu receptors (mu-receptors) are known to interface environmental events, positive (eg, relevant emotional stimuli) and negative (eg, stressors), with pertinent behavioral responses and to regulate motivated behavior.
OBJECTIVE: To examine the degree to which trait impulsiveness (the tendency to act on cravings and urges rather than to delay gratification) is predicted by baseline mu-receptor availability or the response of this system to a standardized, experientially matched stressor. DESIGN, SETTING, AND PATIENTS: Nineteen young healthy male volunteers completed a personality questionnaire (NEO Personality Inventory, Revised) and underwent positron emission tomography scans with the mu-receptor-selective radiotracer carfentanil labeled with carbon 11. Measures of receptor concentrations were obtained at rest and during receipt of an experimentally maintained pain stressor of matched intensity between subjects. MAIN OUTCOME MEASURES: Baseline receptor levels and stress-induced activation of mu-opioid system neurotransmission compared between subjects scoring above and below the population median on the NEO Personality Inventory, Revised, impulsiveness subscale and the orthogonal dimension (deliberation) expected to interact with it.
RESULTS: High impulsiveness and low deliberation scores were associated with significantly higher regional mu-receptor concentrations and greater stress-induced endogenous opioid system activation. Effects were obtained in the prefrontal and orbitofrontal cortices, anterior cingulate, thalamus, nucleus accumbens, and basolateral amygdala-all regions involved in motivated behavior and the effects of drugs of abuse. Availability of the mu-receptor and the magnitude of stress-induced endogenous opioid activation in these regions accounted for 17% to 49% of the variance in these personality traits.
CONCLUSIONS: Individual differences in the function of the endogenous mu-receptor system predict personality traits that confer vulnerability to or resiliency against risky behaviors such as the predisposition to develop substance use disorders. These personality traits are also implicated in psychopathological states (eg, personality disorders) in which variations in the function of this neurotransmitter system also may play a role.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19805703      PMCID: PMC3085183          DOI: 10.1001/archgenpsychiatry.2009.134

Source DB:  PubMed          Journal:  Arch Gen Psychiatry        ISSN: 0003-990X


  85 in total

1.  Mild opioid deprivation increases the degree that opioid-dependent outpatients discount delayed heroin and money.

Authors:  Louis A Giordano; Warren K Bickel; George Loewenstein; Eric A Jacobs; Lisa Marsch; Gary J Badger
Journal:  Psychopharmacology (Berl)       Date:  2002-07-13       Impact factor: 4.530

2.  The effects of nigrostriatal 6-hydroxydopamine lesions on dopamine D2 receptor mRNA and opioid systems.

Authors:  A Mansour; J H Meador-Woodruff; D M Camp; T E Robinson; J Bunzow; H Van Tol; O Civelli; H Akil; S J Watson
Journal:  Prog Clin Biol Res       Date:  1990

Review 3.  The contribution of basal forebrain to limbic-motor integration and the mediation of motivation to action.

Authors:  G J Mogenson; C R Yang
Journal:  Adv Exp Med Biol       Date:  1991       Impact factor: 2.622

Review 4.  Role of dynorphin and enkephalin in the regulation of striatal output pathways and behavior.

Authors:  H Steiner; C R Gerfen
Journal:  Exp Brain Res       Date:  1998-11       Impact factor: 1.972

5.  Efferent connections of the ventral pallidum: evidence of a dual striato pallidofugal pathway.

Authors:  S N Haber; H J Groenewegen; E A Grove; W J Nauta
Journal:  J Comp Neurol       Date:  1985-05-15       Impact factor: 3.215

6.  Biological bases of childhood shyness.

Authors:  J Kagan; J S Reznick; N Snidman
Journal:  Science       Date:  1988-04-08       Impact factor: 47.728

7.  Interactions between serotonin and dopamine in the control of impulsive choice in rats: therapeutic implications for impulse control disorders.

Authors:  Catharine A Winstanley; David E H Theobald; Jeffrey W Dalley; Trevor W Robbins
Journal:  Neuropsychopharmacology       Date:  2005-04       Impact factor: 7.853

8.  Some perspectives on monoamine-opioid peptide interaction in rat central nervous system.

Authors:  H Khachaturian; S J Watson
Journal:  Brain Res Bull       Date:  1982 Jul-Dec       Impact factor: 4.077

9.  Regional reward differences within the ventral pallidum are revealed by microinjections of a mu opiate receptor agonist.

Authors:  P I Johnson; J R Stellar; A D Paul
Journal:  Neuropharmacology       Date:  1993-12       Impact factor: 5.250

Review 10.  Overview and neurobiology of attention-deficit/hyperactivity disorder.

Authors:  Thomas J Spencer; Joseph Biederman; Timothy E Wilens; Stephen V Faraone
Journal:  J Clin Psychiatry       Date:  2002       Impact factor: 4.384

View more
  41 in total

1.  Behavioural activation system sensitivity is associated with cerebral μ-opioid receptor availability.

Authors:  Tomi Karjalainen; Lauri Tuominen; Sandra Manninen; Kari K Kalliokoski; Pirjo Nuutila; Iiro P Jääskeläinen; Riitta Hari; Mikko Sams; Lauri Nummenmaa
Journal:  Soc Cogn Affect Neurosci       Date:  2016-04-06       Impact factor: 3.436

2.  Catechol-O-methyltransferase genotype modulates opioid release in decision circuitry.

Authors:  Jennifer M Mitchell; James P O'Neil; William J Jagust; Howard L Fields
Journal:  Clin Transl Sci       Date:  2013-06-13       Impact factor: 4.689

3.  Impulsive personality and the ability to resist immediate reward: an fMRI study examining interindividual differences in the neural mechanisms underlying self-control.

Authors:  Esther Kristina Diekhof; Lesly Nerenberg; Peter Falkai; Peter Dechent; Jürgen Baudewig; Oliver Gruber
Journal:  Hum Brain Mapp       Date:  2011-09-21       Impact factor: 5.038

Review 4.  The endogenous opioid system in cocaine addiction: what lessons have opioid peptide and receptor knockout mice taught us?

Authors:  Ji Hoon Yoo; Ian Kitchen; Alexis Bailey
Journal:  Br J Pharmacol       Date:  2012-08       Impact factor: 8.739

5.  Personality trait predictors of placebo analgesia and neurobiological correlates.

Authors:  Marta Peciña; Hamdan Azhar; Tiffany M Love; Tingting Lu; Barbara L Fredrickson; Christian S Stohler; Jon-Kar Zubieta
Journal:  Neuropsychopharmacology       Date:  2012-11-16       Impact factor: 7.853

6.  Dysregulation of regional endogenous opioid function in borderline personality disorder.

Authors:  Alan R Prossin; Tiffany M Love; Robert A Koeppe; Jon-Kar Zubieta; Kenneth R Silk
Journal:  Am J Psychiatry       Date:  2010-05-03       Impact factor: 18.112

7.  The association between catastrophizing and craving in patients with chronic pain prescribed opioid therapy: a preliminary analysis.

Authors:  Marc O Martel; Robert N Jamison; Ajay D Wasan; Robert R Edwards
Journal:  Pain Med       Date:  2014-03-10       Impact factor: 3.750

Review 8.  Prefrontal Cortical Opioids and Dysregulated Motivation: A Network Hypothesis.

Authors:  Brian A Baldo
Journal:  Trends Neurosci       Date:  2016-06       Impact factor: 13.837

Review 9.  The multiple facets of opioid receptor function: implications for addiction.

Authors:  Pierre-Eric Lutz; Brigitte L Kieffer
Journal:  Curr Opin Neurobiol       Date:  2013-02-28       Impact factor: 6.627

10.  Dissociable effects of kappa-opioid receptor activation on impulsive phenotypes in wistar rats.

Authors:  Brendan M Walker; Jessica L Kissler
Journal:  Neuropsychopharmacology       Date:  2013-05-21       Impact factor: 7.853

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.